SLITRK1 Binds 14-3-3 and Regulates Neurite Outgrowth in a Phosphorylation-Dependent Manner

Biological Psychiatry

Volumn 66, Issue 10, 2009, Pages 918-925

  Kajiwara, Yuji ^a,c   Buxbaum, Joseph D ^a,c   Grice, Dorothy E ^b,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MARINE BIOLOGICAL LABORATORY   (United States)

Author keywords

secretase; secretase; attention deficit hyperactivity disorder; obsessive compulsive disorder; presenilin; Tourette syndrome; trichotillomania; tumor necrosis factor converting enzyme; yeast two hybrid

Indexed keywords

CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA SECRETASE; PROTEIN; PROTEIN 14 3 3; PROTEIN KINASE C; SLITRK 1 PROTEIN; SLITRK1 INTRACELLULAR DOMAIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENTION DEFICIT DISORDER; BINDING SITE; BRAIN; BRAIN CELL; CARBOXY TERMINAL SEQUENCE; CELL LYSATE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM; ENZYME ACTIVATION; GENE DELETION; GENE MUTATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUMAN CELL; HYBRID; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL CULTURE; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSESSIVE COMPULSIVE DISORDER; PEPTIDE MAPPING; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; YEAST;

14-3-3 PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; EMBRYO, MAMMALIAN; GLYCOSYLATION; HUMANS; IMMUNOPRECIPITATION; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; NEURITES; NEUROBLASTOMA; NEURONS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RATS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 70350572774     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.05.033     Document Type: Article

References (52)

1. Schmucker D. Downstream of guidance receptors: Entering the baroque period of axon guidance signaling. Neuron 40 (2003) 4-6
2. Aruga J., and Mikoshiba K. Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol Cell Neurosci 24 (2003) 117-129
3. Aruga J., Yokota N., and Mikoshiba K. Human SLITRK: Family genes: Genomic organization and expression profiling in normal brain and brain tumor tissue. Gene 315 (2003) 87-94
4. Abelson J.F., Kwan K.Y., O'Roak B.J., Baek D.Y., Stillman A.A., Morgan T.M., et al. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310 (2005) 317-320
5. Stillman A.A., Krsnik Z., Sun J., Rasin M.R., State M.W., Sestan N., et al. Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome. J Comp Neurol 513 (2009) 21-37
6. Albin R.L., and Mink J.W. Recent advances in Tourette syndrome research. Trends Neurosci 29 (2006) 175-182
7. Singer H.S. Tourette's syndrome: From behaviour to biology. Lancet Neurol 4 (2005) 149-159
8. Price R.A., Kidd K.K., Cohen D.J., Pauls D.L., and Leckman J.F. A twin study of Tourette syndrome. Arch Gen Psychiatry 42 (1985) 815-820
9. Hyde T.M., Aaronson B.A., Randolph C., Rickler K.C., and Weinberger D.R. Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology 42 (1992) 652-658
10. Jimenez-Jimenez F.J., and Garcia-Ruiz P.J. Pharmacological options for the treatment of Tourette's disorder. Drugs 61 (2001) 2207-2220
11. Zuchner S., Cuccaro M.L., Tran-Viet K.N., Cope H., Krishnan R.R., Pericak-Vance M.A., et al. SLITRK1 mutations in trichotillomania. Mol Psychiatry 11 (2006) 887-889
12. Katayama K., Yamada K., Ornthanalai V.G., Inoue T., Ota M., Murphy N.P., and Aruga J. Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. [published online ahead of print September 16]. Mol Psychiatry (2008)
13. Gabuzda D., Busciglio J., and Yankner B.A. Inhibition of beta-amyloid production by activation of protein kinase C. J Neurochem 61 (1993) 2326-2329
14. Izumi Y., Hirata M., Hasuwa H., Iwamoto R., Umata T., Miyado K., et al. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J 17 (1998) 7260-7272
15. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., et al. An essential role for ectodomain shedding in mammalian development. Science 282 (1998) 1281-1284
16. Merlos-Suarez A., Ruiz-Paz S., Baselga J., and Arribas J. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J Biol Chem 276 (2001) 48510-48517
17. Dwek R.A., Butters T.D., Platt F.M., and Zitzmann N. Targeting glycosylation as a therapeutic approach. Nat Rev Drug Discov 1 (2002) 65-75
18. Fortini M.E. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat Rev 3 (2002) 673-684
19. Marambaud P., Wen P.H., Dutt A., Shioi J., Takashima A., Siman R., et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114 (2003) 635-645
20. Kimberly W.T., Zheng J.B., Guenette S.Y., and Selkoe D.J. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276 (2001) 40288-40292
21. Artavanis-Tsakonas S., Rand M.D., and Lake R.J. Notch signaling: Cell fate control and signal integration in development. Science 284 (1999) 770-776
22. Edbauer D., Willem M., Lammich S., Steiner H., and Haass C. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277 (2002) 13389-13393
23. Petty H.R. Overview of the physical state of proteins within cells. Curr Protoc Protein Sci (2003) Chapter 1:Unit1.5
24. Okamoto T., Schwab R.B., Scherer P.E., and Lisanti M.P. Analysis of the association of proteins with membranes. Curr Protoc Protein Sci (2001) Chapter 5:Unit 5.4
25. Coblitz B., Wu M., Shikano S., and Li M. C-terminal binding: An expanded repertoire and function of 14-3-3 proteins. FEBS Lett 580 (2006) 1531-1535
26. de Castro E., Sigrist C.J., Gattiker A., Bulliard V., Langendijk-Genevaux P.S., Gasteiger E., et al. ScanProsite: Detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 34 Web Server issue (2006) W362-W365
27. Blom N., Gammeltoft S., and Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294 (1999) 1351-1362
28. Meggio F., and Pinna L.A. One thousand and one substrates of protein kinase CK2?. FASEB J 17 (2003) 349-368
29. Ohtsubo K., and Marth J.D. Glycosylation in cellular mechanisms of health and disease. Cell 126 (2006) 855-867
30. Selkoe D., and Kopan R. Notch and presenilin: Regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26 (2003) 565-597
31. Ebinu J.O., and Yankner B.A. A RIP tide in neuronal signal transduction. Neuron 34 (2002) 499-502
32. Wolfe M.S., and Kopan R. Intramembrane proteolysis: Theme and variations. Science 305 (2004) 1119-1123
33. Buxbaum J.D., Georgieva L., Young J.J., Plescia C., Kajiwara Y., Jiang Y., et al. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol Psychiatry 13 (2008) 162-172
34. Kajiwara Y., Akram A., Katsel P., Haroutunian V., Schmeidler J., Beecham G., et al. FE65 binds Teashirt, inhibiting expression of the primate-Specific caspase-4. PLoS ONE 4 (2009) e5071
35. Berg D., Holzmann C., and Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4 (2003) 752-762
36. Bridges D., and Moorhead G.B. 14-3-3 proteins: A number of functions for a numbered protein. Sci STKE 296 (2005) re10
37. Middleton F.A., Peng L., Lewis D.A., Levitt P., and Mirnics K. Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology 30 (2005) 974-983
38. Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R., Ward H.L., et al. 14-3-3Epsilon is important for neuronal migration by binding to Nudel: A molecular explanation for Miller-Dieker syndrome. Nat Genet 34 (2003) 274-285
39. Toyooka K., Muratake T., Tanaka T., Igarashi S., Watanabe H., Takeuchi H., et al. 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am J Med Genet 88 (1999) 164-167
40. Aitken A. 14-3-3 proteins: A historic overview. Semin Cancer Biol 16 (2006) 162-172
41. Dougherty M.K., and Morrison D.K. Unlocking the code of 14-3-3. J Cell Sci 117 (2004) 1875-1884
42. van Hemert M.J., Steensma H.Y., and van Heusden G.P. 14-3-3 proteins: Key regulators of cell division, signalling and apoptosis. Bioessays 23 (2001) 936-946
43. Fu H., Subramanian R.R., and Masters S.C. 14-3-3 Proteins: Structure, function, and regulation. Annu Rev Pharmacol Toxicol 40 (2000) 617-647
44. Nufer O., and Hauri H.P. ER export: Call 14-3-3. Curr Biol 13 (2003) R391-R393
45. Shikano S., Coblitz B., Wu M., and Li M. 14-3-3 proteins: Regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends Cell Biol 16 (2006) 370-375
46. Mrowiec T., and Schwappach B. 14-3-3 proteins in membrane protein transport. Biol Chem 387 (2006) 1227-1236
47. O'Kelly I., Butler M.H., Zilberberg N., and Goldstein S.A. Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell 111 (2002) 577-588
48. Yaffe M.B., Rittinger K., Volinia S., Caron P.R., Aitken A., Leffers H., et al. The structural basis for 14-3-3: Phosphopeptide binding specificity. Cell 91 (1997) 961-971
49. Ganguly S., Weller J.L., Ho A., Chemineau P., Malpaux B., and Klein D.C. Melatonin synthesis: 14-3-3-dependent activation and inhibition of arylalkylamine N-acetyltransferase mediated by phosphoserine-205. Proc Natl Acad Sci U S A 102 (2005) 1222-1227
50. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families. Am J Hum Genet 80 (2007) 265-272
51. Simonic I., Nyholt D.R., Gericke G.S., Gordon D., Matsumoto N., Ledbetter D.H., et al. Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8q22 and 11q23-24 in South African Afrikaners. Am J Med Genet 105 (2001) 163-167
52. Chung H.J., Huang Y.H., Lau L.F., and Huganir R.L. Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci 24 (2004) 10248-10259